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Centrioles are keymicrotubule polarity determinants.
Centriole duplication is tightly controlled to prevent
cells from developing multipolar spindles, a situation
that promotes chromosomal instability. A conserved
component in the duplication pathway is Plk4, a polo
kinase family member that localizes to centrioles in
M/G1. To limit centriole duplication, Plk4 levels are
controlled through trans-autophosphorylation that
primes ubiquitination. In contrast to Plks 1-3, Plk4
possesses a unique central region called the ‘‘cryptic
polo box.’’ Here, we present the crystal structure of
this region at 2.3 A˚ resolution. Surprisingly, the struc-
ture reveals two tandem homodimerized polo boxes,
PB1-PB2, that form a unique winged architecture.
The full PB1-PB2 cassette is required for binding
the centriolar protein Asterless as well as robust
centriole targeting. Thus, with its C-terminal polo
box (PB3), Plk4 has a triple polo box architecture
that facilitates oligomerization, targeting, and pro-
motes trans-autophosphorylation, limiting centriole
duplication to once per cell cycle.
INTRODUCTION
Centrioles are cylindrical microtubule-based structures that form
the core components of centrosomes and basal bodies, organ-
elles that nucleate and spatially organize microtubules to form
the mitotic spindle and cilia (Bornens, 2012). Centriole number
is precisely controlled with centriole duplication restricted to
a single cell cycle event (Tsou and Stearns, 2006; Tsou et al.,
2009; Nigg and Stearns, 2011). Centrioles exist as pairs com-
posed of an older (mother) centriole and a daughter centriole,
assembled on the mother centriole in the preceding cell cycle.
G1-phase cells contain a single mother-daughter centriole pair.
During S-phase, centrioles separate and duplicate, generating
two mother-daughter pairs that facilitate bipolar spindle
assembly. The mechanisms underlying centriole duplication
define a critical step in cellular biology, as misregulation of
centriole number is linked to chromosome instability andStructure 20, 1905–19diseases including ciliopathies, male sterility, primary micro-
cephaly, and tumorigenesis (Bettencourt-Dias et al., 2011;
Rosario et al., 2010; Nigg and Raff, 2009).
Several proteins are required for centriole biogenesis. Among
these are the conserved proteins Polo-like kinase 4 (Plk4/
Sak), Asterless/Cep152, SAS-6, SAS-5/Ana2/STIL, Cep135,
and SAS-4/CPAP (Song et al., 2008; Azimzadeh and Marshall,
2010). The order of subunit addition suggests a hierarchical
centriole assembly pathway conserved across phyla. Asterless
(Asl), a scaffolding protein, initially recruits Plk4 to the site of
daughter centriole assembly (Hatch et al., 2010; Dzhindzhev
et al., 2010; Cizmecioglu et al., 2010). Plk4 activity is upstream
of the SAS proteins and primes the mother centriole for S-phase
duplication (Pelletier et al., 2006; Kleylein-Sohn et al., 2007; Kita-
gawa et al., 2009). Daughter centriole (procentriole) assembly
begins at the proximal end of the mother centriole with the
formation of a 9-fold symmetric cartwheel structure composed
of SAS-6 homodimers (Kitagawa et al., 2011; van Breugel
et al., 2011). How Plk4 initiates centriole assembly is not well
defined. In Caenorhabditis elegans, ZYG-1 (the Plk4 homolog)
phosphorylates SAS-6, triggering centriole formation (Kitagawa
et al., 2009), although this has not been shown in other systems.
In humans, Plk4 inactivates FBXW5, a SCF (Skp, Cullin, F-box)
component used to degrade SAS-6, suggesting that Plk4 initi-
ates centriole duplication by stabilizing SAS-6 (Puklowski et al.,
2011). However, Drosophila FBXW5 has no role in controll-
ing centrosome number (Rogers et al., 2009). Thus, whereas
species show some divergence in the duplication pathway,
Plk4 has emerged as a master-regulator of centriole assembly.
Plk4 and its binding partner Asl are required for centriole
duplication (Bettencourt-Dias et al., 2005; Habedanck et al.,
2005; Varmark et al., 2007) and studies in human, Drosophila,
and Xenopus systems show that Plk4 or Asl overexpression
promotes centriole amplification as well as de novo centriole
assembly (Rodrigues-Martins et al., 2007; Peel et al., 2007;
Dzhindzhev et al., 2010; Eckerdt et al., 2011). Plk4 is regulated
by the SCFSlimb/b-TrCP ubiquitin ligase that recognizes Plk4
after homodimer-dependent trans-autophosphorylation of the
phosphodegron known as the downstream regulatory element
(DRE) (Guderian et al., 2010, Cunha-Ferreira et al., 2009; Rogers
et al., 2009; Brownlee et al., 2011; Holland et al., 2010). In
cultured Drosophila cells, Plk4 is degraded throughout most of
the cell cycle to prevent centriole amplification (Peel et al.,
2007; Kleylein-Sohn et al., 2007). During M-phase, however,17, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1905
Figure 1. The Plk4 CPB Is Composed of
Tandem PB Domains PB1 and PB2
(A) Polo-like kinase family domain architecture.
Plk1-3 contain two PB domains, Plk4 contains
three PB domains. Plk4 levels are regulated by the
DRE (orange).
(B) Secondary structure topology diagram of
Plk4’s conserved central domain: PB1 (b strands
in green, a helix in yellow, stirrup in red, loops in
black) and PB2 (b strands in blue, a helix in orange,
loops in black).
(C) Tertiary structure of the Plk4 PB1-PB2 mono-
mer colored as in (B).
(D) Quaternary structure of homodimeric Plk4
PB1-PB2, rotated 90 relative to (C).
(E) Stick representation of the junction between
PB1 1a1 and PB2 where the T449 hydroxyl caps
the 1a1 helix.
(F) Stick representation of the PB2 intradomain
disulfide formed between 2a1 C566 and 2b2
C511. Final 2Fo-Fc electron density contoured at
1.5s (E,F).
Structure
Structure of the Plk4 Cryptic Polo BoxPlk4 is dephosphorylated by Protein Phosphatase 2A, thereby
stabilizing Plk4, allowing a brief mitotic debut that restricts
centriole duplication to a single event per cell cycle (Brownlee
et al., 2011).
Plk4 is a member of the Polo-like kinase family. Plk members
1–4 share sequence similarity to the founding member,
Drosophila Polo (Plk1) (Sillibourne and Bornens, 2010). Like
Polo, Plk members regulate cell-cycle events that collectively
include spindle formation, the metaphase-to-anaphase transi-
tion, mitotic exit, cytokinesis, and DNA damage checkpoints.
To perform these critical functions, Plk gene expression, protein
expression, localization, kinase activity, and destruction are
tightly regulated throughout the cell cycle (Archambault and
Glover, 2009) as aberrant Plk activities contribute to chromo-
some instability and oncogenesis.
Plks share an amino-terminal serine/threonine kinase domain,
as well as one or more 100 residue polo box (PB) domains. Plk
members 1–3 contain two carboxy-terminal PBs (Figure 1A) that
interact in cis to bind phosphorylated targets, mediate localiza-
tion, and activate the kinase (Lowery et al., 2005). The architec-1906 Structure 20, 1905–1917, November 7, 2012 ª2012 Elsevier Ltd All rights reservedture of a PB domain consists of an anti-
parallel six-stranded b sheet that lies
across a C-terminal a helix (Leung et al.,
2002). Plk1’s tandem PBs (PB1-PB2)
clamp around a phosphopeptide target
with each PB contributing binding deter-
minants (Elia et al., 2003; Cheng et al.,
2003). Intriguingly, Plk4 is structurally
divergent. It was annotated as containing
only a single carboxy-terminal PB, which
confers homodimerization and moderate
centriole localization by binding an un-
identified target (Leung et al., 2002). The
structure of the Plk4 PB is homodimeric
and adheres to a general PB architecture,
though it is formed through swapped
chains of the homodimer. The homodi-meric arrangement of this Plk4 PB is distinct from the tandem
arrangement of the Plk1 PB1-PB2 pair, indicative that PBs adopt
differential spatial arrangements.
Plk4 also contains a conserved central domain, hitherto called
the ‘‘cryptic polo box’’ (CPB), which bridges the kinase domain
and the carboxy-terminal PB. This region was initially identified
as a centriole-targeting component capable of binding the
kinase domain in trans (Leung et al., 2002). Based on these prop-
erties, the region was named the ‘‘cryptic polo box’’ though it
showed no apparent sequence homology to canonical PBs
(Swallow et al., 2005). Recent work has identified a CPB binding
partner, Asterless (Asl)/Cep152, which targets Plk4 to centrioles
(Dzhindzhev et al., 2010; Hatch et al., 2010, Cizmecioglu et al.,
2010). To date, the CPB has largely remained an enigma, with
questions concerning its structure, function in centriole localiza-
tion, and role in Plk4 activity outstanding.
Here, we present the crystal structure of the CPB, determined
to a resolution of 2.3 A˚. Surprisingly, this structure reveals that
the CPB comprises two structurally unique PB domains, PB1
and PB2. Cellular localization and biochemical studies indicate
Table 1. Crystallographic Data, Phasing, and Refinement
Crystal Native SeMet M517A
Beamline APS 22-ID APS 22-BM
Space group P21212
Cell: a,b,c (A˚) 86.5, 136.4, 46.5 87.1, 136.5, 46.6
Wavelength (A˚) 1.00890 0.97980
dmin (A˚) 2.3 (2.38-2.30) 2.9 (3.00-2.90)
% Complete 90.1 (85.2) 100.0 (100.0)
<I/sI> 21.3 (5.2) 16.3 (3.2)
Number of observations 114,559 (10,620) 101205 (9,570)
Number of independent
observations
22,630 (2,082) 23604 (2,333)
Multiplicity 5.1 (5.1) 4.3 (4.1)
Rsym (%)
a 5.9 (35.9) 8.5 (37.9)
Resolution (A˚) at which
anomalous completeness
exceeds 85% for I/sI > 5,
> 3, > 2
4.1, 3.9, 3.4
Overall log-likelihood
gainb/figure of meritc
1.4 3 105 /
0.44 (0.35)
Figure of meritc 0.25 (0.25) /
0.47 (0.36)Centrics/acentrics
Figure of meritc after
density modification
0.66 (0.42) /
0.73 (0.52)
Centrics/acentrics
Refinement (A˚) 50-2.3 (2.38-2.30)
R valued 18.5 (19.8)
Rfree
e 25.5 (30.7)
Rmsd bond lengths (A˚) 0.008
Rmsd bond angles () 1.09
Mean B (min/max) (A˚2) 35.9 (9.4 / 141.6)
Number of atoms:
protein/water/SO4

3478/184 /6
Values in parentheses are for the highest resolution shells unless other-
wise denoted.
aRsym = ShSijIi(h)  < I(h) > j/ ShSiIi(h) where Ii(h) is the integrated intensity
of the ith reflection with the Miller Index h and < I(h) > is the average over
Friedel and symmetry equivalents.
bLog-likelihood gain value as determined by Phenix.
cFigure of merit is the weighted mean of the cosine of the deviation from
abest.
dR value = S(jFobsjkjFcalcj)/SjFobsj.
eRfree is calculated using a 10% subset of the data that is removed
randomly from the original data and excluded from refinement.
Structure
Structure of the Plk4 Cryptic Polo Boxthat the entire tandem PB1-PB2 cassette is required for robust
centriole localization and Asl binding. The PB1-PB2 cassette
also mediates Plk4 oligomerization, and when expressed as
a trans cassette, protects endogenous Plk4 from trans auto-
phosphorylation and subsequent degradation. Thus, the Plk4
PB1-PB2 cassette is a unique architectural component required
for Plk4 function.
RESULTS
Crystallization and Structure Determination of the Plk4
CPB
Plk4’s central region, termed the CPB, was analyzed using
secondary structure prediction algorithms in parallel with
conservation to delineate the boundary residues for structural,
biochemical, and cellular analysis. D. melanogaster Plk4382-602
was bacterially expressed, purified, and crystallized as
described in the Experimental Procedures. Crystals belonged
to the space group P21212. A native data set was collected on
a single crystal to a resolution of 2.3 A˚. To obtain phasing infor-
mation, selenomethionine (SeMet)-derivatized protein was
produced but proved insoluble. We found that a SeMet-M517A
mutant wasmarginally soluble and produced isomorphous crys-
tals. Single wavelength peak anomalous dispersion data to 2.9 A˚
resolution was collected. Phases were calculated and extended
to 2.3 A˚. The structure was built and refined to R and Rfree factors
of 18.5 and 25.5%, respectively. The final model contains two
molecules of Plk4 in the asymmetric unit, comprising residues
382–596 (chain A) and 382–548, 553–597 (chain B). Crystallo-
graphic information is presented in Table 1.
The CPB Is Composed of Two Structurally Unique PB
Domains
Plk4382-602 forms a multidomain structure, surprisingly com-
posed of two tandem structurally unique PBs (Figures 1B–1D).
This contrasts with the prediction that Plk4 is composed of
a single C-terminal PB. In contrast to Plk1-3 that each contain
two PBs, Plk4 was designated the ‘‘odd one out’’ (Sillibourne
and Bornens, 2010), which holds true, though not because it
contains one PB, but three PBs. We henceforth demarcate the
Plk4382-602 PBs and assign them the sequential numbering
PB1 (aa 382–499) and PB2 (aa 500–602), and propagate this
scheme to the ultimate C-terminal PB, not included in our struc-
ture, assigning it PB3 (aa 660–741). We refer to the structure
reported here as PB1-PB2. Both PB1 and PB2 adopt a canonical
PB fold, delineated by an N-terminal antiparallel b sheet that
packs against a C-terminal helix that runs diagonal to the
b strands. PB1 has a sequential antiparallel b sheet composed
of the six strands 1b1-1b2-1b3-1b4-1b5-1b6 that pack against
the 1a1 helix. PB1 contains two unique structural attributes.
First, the 1b3-1b4 strands form an extended hairpin off the
b sheet, giving PB1 a winged structure (Figures 1C and 1D,
green arrows). Second, a 16 residue segment that we term the
‘‘stirrup’’ bridges 1b5 and 1b6 and blankets one face of the
b sheet, effectively sandwiching the PB1 b sheet between 1a1
and the stirrup (Figures 1C and 1D, red arrows). The 1b4 portion
of the winged b-hairpin buttresses the N-terminal flank of the
stirrup, implicating a structural codependence between these
unique PB elements. The 1a1 helix completes PB1, followedStructure 20, 1905–19by a two amino acid linker that bridges PB1 and PB2: threonine
499 and proline 500. T499 is conserved across species and caps
the 1a1 helix by forming a hydrogen bond between the T499
g-hydroxyl and the K496 backbone carbonyl (Figure 1E). The
invariant proline P500 makes a jog in the backbone, offsetting
the first strand of the PB2 sheet, 2b1, from the 1a1 axis.
Plk4 PB2 also contains unique features that deviate from the
canonical PB fold, including secondary structure elements that
flank the b sheet as well as an extended 2a1 helix. The PB2
b sheet proceeds in an antiparallel fashion, consecutively snak-
ing through strands 2b1-2b2-2b3-2b4-2b5. Instead of forming17, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1907
Figure 2. Plk4 PB1-PB2 Is an Asymmetric
Homodimer with Plastic Stirrups and Loops
(A) Superposition of Plk4 PB1-PB2 protomers A
and B showing plasticity in the stirrup as well as
the 2b4-2b5 and 2b5-2a1 loops. Plk4 colored as in
Figure 1B, shown in cartoon format.
(B–D) Plk4 PB1-PB2 protomer A backbone
colored and scaled according to Ca B-factor
values ranging from 14 (dark blue) to 105 (red) A˚2.
High B-factors correlate with the structurally
plastic loop segments between protomers A and B
(shown in A). The region bridging PB1 and PB2
shows little structural divergence and is domi-
nated by low B-factor values. Plk4 PB1-PB2 pro-
tomer A (C), and protomer B (D) shown in sphere
format; oriented as shown in the inset. Residues
involved in homodimerization from both pro-
tomers, unique to protomer A, and unique to
protomer B are colored dark gray, purple, and
raspberry, respectively.
(E) Size exclusion chromatography—multi-angle
light scattering analysis of H6-Plk4 PB1-PB2 in-
jected at 19 mM (red trace) and 28 mM (green trace)
(100 ml). The y axis at left displaysmolecular weight
(kDa), y axis at right displays normalized differen-
tial refractive index, x axis displays time compo-
nent of the run.
See also Figure S1.
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Structure of the Plk4 Cryptic Polo Boxa sixth consecutive b strand, as is the case with PB1, PB2 2b5 is
followed by an ordered loop that connects 2b5 with the 2a1 helix
(Figures 1C and 1D, gray arrows). The 2b5-2a1 loop is stabilized
by a hydrogen bond between the conserved D542 dO and the
M546 backbone amide as well as van der Waals interactions
between hydrophobic residues in the loop, the 2b5 strand, and
the 2a1 helix. The C-terminal region of this loop is variable across
species and contains a 7 residue insert in higher eukaryotes. The
2a1 helix runs diagonal to the b sheet, spanning 40 A˚ and extend-
ing 13 A˚ past the 2b1 strand (Figure 1C, orange arrow). The helix-
sheet interaction is stabilized both by a hydrophobic core as well
as a disulfide bond between C511 in 2b2 and C566 in 2a1 (Fig-
ure 1F). The 2a1 helix leads into a loop that curls back toward
2b1, effectively stabilizing the extended 2a1 helix by packing
F588 against the b sheet-2a1 hydrophobic core. The loop termi-
nates at an invariant proline, P589, that facilitates a bend in the
backbone, leading into PB20s final b strand, 2b6, which runs
parallel to 2b1 and completes the PB2 b sheet and the PB1-
PB2 cassette (Figure 1C, blue arrow). The location and polarity
of the Plk4 2b6 strand is unique, normally running antiparallel
to b5 in other PB structures.
Collectively, PB1 and PB2 form a composite structure, with
a conserved core interface that buries 329 A˚2 and limits molec-
ular flexibility to peripheral loop regions. Relative to PB1, PB2
is rotated approximately 120. The protomers align well with1908 Structure 20, 1905–1917, November 7, 2012 ª2012 Elsevier Ltd All rights reserved1.2 A˚ rmsd across 214 Ca atoms. PB1
and PB2 individually align to their dimeric
mate with a Ca rmsd equal to 1.1 A˚ and
1.2 A˚, respectively. Structural differences
between the protomers, indicative of
molecular flexibility, localize to loop re-
gions, specifically the stirrup’s C-terminalregion, the 2b4-2b5 loop, and the 2b5-2a1 loop (Figure 2A, red
arrows). As a second metric for structural flexibility, we mapped
B factors on the PB1-PB2 structure. The structure’s Ca
B-factors range from 14-105 A˚2, with increased levels in the
stirrup, the 2b4-2b5 loop, the 2b5-2a1 loop, and the 2a1-2b6
loop, correlating with structural differences noted in the align-
ment of the protomers (Figure 2B, arrows). The core regions of
PB1 and PB2 as well as the T499-P500 bridge exhibit low
temperature factors and little structural divergence when proto-
mers are compared, indicating that the relative arrangement of
PB1 and PB2 is static.
Plk4 PB1-PB2 Forms a Pseudosymmetric Homodimer
The two Plk4 PB1-PB2 molecules in the asymmetric unit form
a homodimer. The two PB1-PB2 molecules are related by
a pseudosymmetric 2-fold axis that runs parallel to the 1a1
helices (Figure 1D). A translational component along the pseudo
2-fold axis shifts protomer A approximately 5 A˚ relative to
protomer B. The homodimerization interface is mediated by
PB1-PB1 contacts as well as PB2-PB2 contacts (Figures 2C
and 2D). Due to the translational component, nonequivalent
sets of residues are involved in the asymmetric dimerization.
The PB1-PB1 interface primarily involves residues from 1a1
with additional contributions from neighboring residues in the
b sheet. The PB2-PB2 interface involves residues from 2b4,
Structure
Structure of the Plk4 Cryptic Polo Boxthe 2b4-2b5 loop, 2b5, and 2a1. The PB1-PB1 and PB2-PB2
dimerization interfaces bury 1511 A˚2 and 1065 A˚2 of solvent
accessible surface area, respectively, collectively totaling
2576 A˚2. Whereas crystallographic interfaces between proto-
mers exist (see Figures S1A–S1C, available online), the homo-
dimer in the asymmetric unit buries the largest surface area
and is the only interaction that involves both PB1 and PB2;
thus, it likely represents the biological dimer.
To verify that Plk4 PB1-PB2 forms an oligomeric species
in solution, we analyzed the oligomeric state using light scat-
tering. Size exclusion chromatography coupled to multiangle
static light scattering was conducted at pH 7.0. His6-Plk4
PB1-PB2 protein (MW 27.6 kDa) was injected at initial concen-
trations of 19 and 28 mM.Single elution peaks had experimentally
determined molecular weights equal to 56.3 ± 4 kDa and 54.3 ±
2 kDa, respectively (Figure 2E; Figure S1D). We also investigated
the oligomeric state using batch dynamic light scattering at
pH 9.5 using 140 mM Plk4 PB1-PB2 (MW 25.7 kDa), which
yielded an experimental mass of 66 ± 16 kDa (Table S1). Collec-
tively, the static and dynamic light scattering values indicate that
Plk4 PB1-PB2 exists as a homodimer with potential higher order
oligomers forming at elevated concentration and pH. This is
supported by prior work showing that the mouse Plk4 PB1-
PB2 region self-associates (Leung et al., 2002).
Unique Features of Plk4 PB1 and PB2 and Implications
for Target Binding
Whereas Plk4 PB1 and PB2 contain characteristic features of
a PB domain, each diverges from PB structures determined to
date, yielding implications for target binding. To highlight these
differences, we compare Plk4’s PB1 and PB2 domains with
Plk1’s PB1 domain bound to a phosphopeptide target (Fig-
ure 3A). The Plk1 PB1 1b1 strand forms key contacts with the
phosphopeptide target. The Plk4 PB1 domain aligns to Plk1
PB1 with an rmsd of 2.0 A˚ across 76 aligned Ca atoms (Fig-
ure 3B). Structural divergence occurs at the Plk4 PB1 1b3-1b4
hairpin extension, the stirrup, the positioning of 1b6, and the
elongated 1a1 N-terminal region. Whereas there is structural
divergence, the 1b1 strand, used in Plk1 PB1 to bind phospho-
peptide targets, is accessible and may facilitate target binding
as observed in Plk1 PB1 (Figure 3C).
Plk4 PB2 diverges from the Plk1 PB1 structure, with differ-
ences in loops, a helix extension, and the positioning of 2b6.
Plk4 PB2 aligns to Plk1 PB1with a 2.3 A˚ rmsd over 72 structurally
aligned Ca atoms (Figure 3B). Plk4 PB2 differs from Plk1 PB1 in
the positioning of the 2b2-2b3 and 2b4-2b5 loops. Plk4 PB2
contains an ordered loop between 2b5 and 2a1 that substitutes
for the Plk1 PB1 1b6 strand. Plk4 PB2 forms a C-terminal exten-
sion on the 2a1 helix. The Plk4 PB2 2b6 strand does not occur
between 2b5 and 2a1, but resides C-terminal to 2a1 and runs
parallel to 2b1, a site occupied by the phosphopeptide target
in Plk1 PB1. Thus, 2b6 occludes the Plk4 PB2 domain from
interacting with a phosphopeptide in a manner equivalent to
Plk1 PB1.
Plk4 PB1-PB2 Has a Novel Interdomain and
Homodimeric Arrangement
PB structures determined to date show diverse intra- and inter-
molecular PB-PB interactions. Here we compare Plk4 PB1-PB2Structure 20, 1905–19with Plk1 PB1-PB2 and Plk4 PB3. Plk1 PB1-PB2 is monomeric,
with PB1 and PB2 positioned to form a collective b sandwich. In
contrast, Plk4 PB3 is homodimeric and dimerizes across a
symmetric b sandwich (Leung et al., 2002). Like Plk1 PB1-PB2,
the Plk4 PB3 b sheets are sandwiched orthogonal to one
another; however, PB3 dimerizes across the opposite face of
its PB b sheets. Plk4 PB1-PB2 adopts a third, unique PB domain
arrangement (Figures 3C and 3D). To highlight the differential
interdomain arrangements across these paired PB domain
structures, we superimposed the Plk4 PB1-PB2 structure and
the Plk1 PB1-PB2 structure after a least-squares fit of their
respective PB1 domains (Figure 3C). Relative to PB1, the Plk4
PB2 domain is positioned dramatically differently than Plk1
PB2, each engaging a distinct, nonoverlapping face on their
respective PB1 partner. In Figure 3D, the Plk4 PB1-PB2 struc-
ture is superimposed on the Plk4 PB3-PB3 structure after
a least-squares fit of individual Plk4 PB1 and PB3 domains.
The position of the PB3 dimeric mate does not correlate with
the relative positioning of PB2 or the PB1 dimeric mate. Overall,
all PB-PB structures exhibit nonhomologous domain arrange-
ments. One consistent feature across Plk4 PB structures is
homodimerization of the individual PB domains. However,
whereas the PB3-PB3 interface is symmetric, the PB1-PB1
and PB2-PB2 interfaces are asymmetric.
The Conserved Plk4 PB1-PB2 Interdomain Groove
Corresponds to the Plk1 PB1 Target Binding Site
To highlight conserved determinants across the Plk4 PB1-PB2
structure, we generated an alignment of PB1-PB2 across ten
diverse species and contoured identity at 100% and 80% (Fig-
ure 4A, green and yellow, respectively). When mapped onto
the Plk4 PB1-PB2 homodimer structure, the prime cluster of
invariant residues occurs at a composite site formed at the
PB1-PB2 junction, with contributions by PB1 1b1-1b2 and PB2
2b1-2b4 (Figures 4B and 4C, green arrows). The majority of
conserved sequences in PB1 1b2-1b5 are occluded by the
stirrup, and accessibility would thus require a dramatic rear-
rangement of the stirrup, which we do not rule out. The PB1-
PB2 junction is formed on a single protomer, thereby constituting
two independent sites on the homodimer. The PB1-PB2 junction
is concave with both hydrophobic and basic determinants
(Figures 4B and 4C, blue arrows). When Plk1 PB1 with bound
phosphopeptide is aligned with Plk4 PB1, the phosphopeptide
is positioned at the Plk4 PB1-PB2 conserved junction (Figures
3C, 4B, and 4C). Whether this site on Plk4 binds targets remains
to be determined.
The Full Plk4 PB1-PB2 Cassette Is Required for
Asterless Binding
A fragment of Plk4’s PB1-PB2 region has been shown to bind the
centriole component Asl in vitro (Dzhindzhev et al., 2010). The
Asl-binding region spans Plk4 residues 376–525, whereas
a shorter fragment spanning residues 376–500 (encompassing
only PB1) lacks Asl-binding activity. The Plk4 PB1-PB2 structure
spans residues 382–602 with proline P500 defining the PB1-PB2
bridge and residues 501–525 encoding the first three contiguous
antiparallel b strands in PB2 (2b1-2b3). Whereas 2b1-2b3 is
conserved and contributes to the composite PB1-PB2 con-
served patch, it is unlikely that 2b1-2b3 would fold into an17, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1909
Figure 3. Plk4 PB1 and PB2 Diverge from Plk1 PB Domain Structures and Form a Unique Interdomain Interaction
(A) Structural alignment of Plk4 PB1 and Plk4 PB2 (colored as in Figure 1B) with human Plk1 PB1 bound to a phosphopeptide target (3FVH, b strands in purple,
a helix in gray, peptide in blue).
(B) Matrix showing the rmsd (A˚) between structures of human Plk1 PB1 and PB2, fly Plk4 PB1 and PB2, and mouse Plk4 PB3.
(C) Superposition of Plk4 PB1-PB2 homodimer and the Plk1 PB1-PB2-phosphopeptide structure, aligned over Plk4 PB1 and Plk1 PB1, highlighting the
differential organization of Plk1 PB1-PB2 as compared to Plk4 PB1-PB2. The Plk4 PB1 stirrup overlaps with the corresponding binding site of Plk1 PB2. The
location where Plk1 PB1 binds its phosphopeptide target is accessible on Plk4 PB1.
(D) Superposition of Plk4 PB1-PB2 and the Plk4 PB3 homodimer, aligned over single PB1 and PB3 domains. Insets show the orientation of each independent
structure (C and D).
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Structure of the Plk4 Cryptic Polo Boxordered b sheet in the absence of 2a1, though it may fold upon
Asl binding. To test the ability of Plk4 PB1-PB2 to bind Asl, taking
structural insight into construct design, we immunoprecipitated
various Plk4-GFP constructs from S2 cell lysates transiently
coexpressing the Asl Plk4-binding domain, V5-Asl (residues
1-300), and immunoblotted for these proteins. As expected,
full-length Plk4 did not express at high levels, because of its
ubiquitin-mediated degradation, and thus did not coimmunopre-
cipitate detectable levels of Asl (Figure 4D). To ensure that Plk4
was capable of immunoprecipitating Asl, we examined a full-
length Plk4 Slimb Binding Mutant (SBM), S293A/T297A, that
prevents phospho-dependent Slimb binding and concomitant1910 Structure 20, 1905–1917, November 7, 2012 ª2012 Elsevier LtdPlk4 ubiquitination, yielding stable Plk4 (Rogers et al., 2009).
Plk4-SBM-GFP was stably expressed and coimmunoprecipi-
tates Asl (Figure 4E). Intriguingly, Plk4 lacking PB1 (Plk4 DPB1)
expressed to a high level, implicating a possible role for PB1 in
Plk4 degradation (Figure 4D). However, Plk4 DPB1 failed to
coimmunoprecipitate Asl. Strikingly, expression of only PB1-
PB2 (residues 382–602) robustly coimmunoprecipitated Asl. In
contrast, a construct containing the previously described Plk4
Asl-binding domain Plk4 PB1+ (residues 382–525) exhibited
low expression and failed to coimmunoprecipitate detectable
levels of Asl, suggesting that the full PB1-PB2 structural cassette
is required for robust Asl binding in vivo.All rights reserved
Figure 4. Plk4 PB1 and PB2 Form a Composite Interdomain Groove Delineated by Conserved and Basic Residues
(A) Plk4 sequence alignment across ten species. Protomer A solvent accessible surface area (ASA) (A˚2) is indicated;100% identity is highlighted in green, 80%
identity in yellow (homologous residues also highlighted in yellow where the 80% identity criteria is met). Human Plk1 PB1 sequence is aligned against Plk4 PB1
and PB2, based on structural alignment. Residues involved in homodimerization are indicated below the alignment, colored as in Figures 2C and 2D.
(B) Plk4 PB1-PB2 homodimer structure shown in sphere format with conserved residues colored as in (A) (left) and in surface representation (right) showing
electrostatics contoured from 2.0 to +2.0 kT/e.
(C) Protomer A rotated 45 relative to the orientation shown in (B), showing conservation and electrostatics as in (B). The phosphopeptide from the Plk1 PB1-PB2
structure (3FVH) shown in stick format and colored blue, is docked onto the Plk4 structure in both (B) and (C), based on the structural alignment of Plk1 PB1 and
Plk4 PB1 shown in Figure 3C.
(D and E) Anti-GFP immunoprecipitates from S2 cell lysates transiently expressing N-terminal Asl-V5 and the indicated Plk4-GFP construct or control GFP,
probed for GFP and V5.
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Figure 5. The Plk4 PB1-PB2 Cassette Is
Required for Robust Centriole Localization
(A) Schematic of PB-GFP containing constructs
assayed for centriole localization.
(B) S2 cells were transiently transfected with the
constructs shown in (A) (green), induced to
express for 24 hr, and immunostained with anti
D-PLP antibody to mark centrioles (red). Centriole
colocalization was classified as strong, weak, or
no colocalization. Total number of cells analyzed
and independent experiments performed noted at
right.
(C and D) Expression of PB1-PB3 (B) or the
PB1-PB2 cassette (D) results in strong centriole
co-localization. Cell margins are indicated (white
dashed lines).
(E–I) Single or incomplete PBs primarily display
weak or no centriole colocalization. Representa-
tive images of differential localization are shown.
Boxed regions are magnified in the lower panels.
Scale, 5 mm.
Structure
Structure of the Plk4 Cryptic Polo BoxThe PB1-PB2 Cassette Is Necessary and Sufficient for
Robust Centriole Targeting
In light of our finding that the CPB is composed of two bona fide
PB domains, we set out to determine whether individual PBs
could mediate centriole localization or if the full PB1-PB2 struc-
ture was required for centriole targeting. Localization experi-
ments were conducted in interphase S2 cells containing endog-
enous Plk4, as Plk4 depletion causes dramatic centriole loss.We
transiently expressed a series of inducible Plk4 PB-GFP con-
structs (Figure 5A). After transgene induction, cells were immu-
nostained for pericentrin-like protein (D-PLP) to mark centrioles
and colocalization was scored as strong, weak, or no centriole
localization (Figures 5B–5I). Only two constructs, PB1-PB3 (aa
382–741) and PB1-PB2 (aa 382–602), containing the entire
PB1-PB2 cassette defined in our crystal structure, displayed1912 Structure 20, 1905–1917, November 7, 2012 ª2012 Elsevier Ltd All rights reservedrobust centriole localization. PB1-PB3
and PB1-PB2 strongly colocalized with
centrioles in 88% and 96% of cells
assayed, respectively (Figures 5B–5D).
Examination of constructs lacking the
full PB1-PB2 cassette showed signifi-
cantly reduced centriole colocalization.
Expression of the single PB domains
that compose the PB1-PB2 cassette indi-
vidually displayed no centriole localiza-
tion in themajority of cells scored (Figures
5B, 5E, and 5F). We also scored the
centriole targeting activity of the previ-
ously described Plk4 Asl-binding region
(PB1+) (Dzhindzhev et al., 2010). PB1+
displayed a dramatic reduction in cen-
triole colocalization as compared to
PB1-PB2 (Figures 5B and 5G), suggest-
ing that the full PB1-PB2 cassette is
necessary to bind Asl and target Plk4
to centrioles. To determine whether the
PB1-PB2 cassette is necessary for cen-
triole targeting, we designed a full-lengthSBMconstruct with the PB1-PB2 cassette deleted (SBMD[PB1-
PB2]). SBM D[PB1-PB2] showed strong centriole colocalization
in only 6% of cells and weak colocalization in 49% of cells
(Figures 5B and 5H). [PB1-PB2]-independent centriole associa-
tion is likely conferred by PB3, as mouse PB3 has weak centriole
targeting activity (Leung et al., 2002). In agreement, we found
that a Linker-PB3 construct (L-PB3; aa 602–741) showed some
level of centriole colocalization in 49% of cells (Figures 5B
and 5I).
PB1-PB2 Scaffolds Plk4 Trans-Autophosphorylation
to Limit Centriole Duplication
Previous work has revealed an autoregulatory mechanism in
Plk1 whereby its PB1-PB2 cassette binds the kinase domain in
trans and inhibits kinase activity in vitro. It has also been shown
Structure
Structure of the Plk4 Cryptic Polo Boxthat the mouse Plk4 central region (encompassing PB1-PB2)
can bind the Plk4 kinase domain in trans (Leung et al.,
2002). To determine whether inhibition of kinase activity is
a conserved PB feature, we incubated a fly Plk4 construct con-
taining the kinase domain + DRE (Kin-DRE) with increasingmolar
ratios of the PB1-PB2 cassette or the PB3 domain and assayed
Plk4 autophosphorylation. No change in autophosphorylation
was detected upon titration with PB1-PB2 or PB3 in trans
(Figure S2).
Endogenous Plk4 levels are tightly regulated through trans-
autophosphorylation of the DRE. Trans-autophosphorylation
should be promoted by Plk4 oligomerization. Given that our
PB1-PB2 structure is homodimeric, we tested whether expres-
sion of the PB1-PB2 cassette could inhibit Plk4 degradation by
heterodimerizing with full-length Plk4 and preventing trans-
autophosphorylation. We first analyzed Plk4 stabilization by
assessing centriole number, as increased Plk4 stabilization pro-
motes centriole amplification. Cells transfected with full-length
Plk4 or nondegradable Plk4-SBM resulted in centriole amplifica-
tion, with Plk4-SBM generating a stronger effect (Rogers et al.,
2009). Strikingly, cells transfected with PB1-PB2 displayed
centriole amplification on par with Plk4-SBM (Figures 6A and
6B, Figure S3). Other Plk4 constructs including Plk4-DPB1,
Plk4-D[PB1-PB2], and PB1+ did not alter the centriole count
from the GFP control, indicating that the entire PB1-PB2
cassette is required to stimulate centriole amplification, pre-
sumably by hyper-stabilizing endogenous Plk4. Whereas low
PB1-PB2 induction levels caused centriole amplification, this
effect varied slightly at higher induction levels, potentially due
to PB1-PB2 homodimers saturating centriole binding sites
(Figure S4).
To directly test whether PB1-PB2 promotes centriole amplifi-
cation through stabilization of Plk4, we cotransfected full-length
Plk4-GFP with PB1-PB2-GFP, Plk4-D[PB1-PB2]-GFP, or GFP
and analyzed Plk4-GFP levels. We found that full-length Plk4-
GFP levels increased dramatically when cotransfected with
PB1-PB2-GFP but not with Plk4-D[PB1-PB2]-GFP or GFP alone,
demonstrating that PB1-PB2 promotes Plk4 stability in trans
(Figure 6C). To test whether PB1-PB2-GFP could bind Plk4-
FL-myc in trans, we cotransfected these constructs, immuno-
precipitated PB1-PB2-GFP, and probed for Plk4-FL-myc. We
found that PB1-PB2-GFP was able to immunoprecipitate Plk4-
FL-myc, indicative of an interaction mediated by PB1-PB2
(Figure 6D). Both PB1-PB2 and PB3 independently confer dimer-
ization. We asked whether Plk4 homodimerization, as mediated
by PB1-PB2, is required for efficient trans-autophosphorylation
and degradation or whether PB3-mediated dimerization suf-
fices. To test this, we expressed a construct containing PB3
but lacking PB1-PB2 (Plk4-D[PB1-PB2]-GFP) and compared
its levels to wild-type Plk4-GFP and a stable full-length Plk4
kinase-dead mutant (Figure 6E) (Brownlee et al., 2011). Wild-
type Plk4-GFP protein levels were extremely low. In contrast,
Plk4-D[PB1-PB2] protein levels were dramatically stabilized
and on par with kinase-dead Plk4. To ensure that Plk4-GFP
was expressed in these cells and could be compared to Plk4-
D[PB1-PB2], we depleted Slimb via RNAi and immunoblotted
for GFP. Slimb depletion yielded detectable Plk4-GFP, confirm-
ing Plk4 expression and its Slimb-mediated degradation (Fig-
ure 6F). These findings indicate that PB1-PB2 plays a key roleStructure 20, 1905–19in Plk4 degradation beyond homodimerization and may extend
to scaffolding the kinase for trans-autophosphorylation (Guder-
ian et al., 2010). To test whether PB1-PB2 plays a role in auto-
phosphorylation of the DRE, we examined Slimb binding as
a read-out for DRE phosphorylation. Plk4-FL-GFP ran as a broad
band on SDS PAGE and was able to coimmunoprecipitate
Slimb; however, Plk4-D[PB1-PB2]-GFP ran as a tight doublet
and coimmunoprecipitated comparatively reduced levels of
Slimb, indicating that the PB1-PB2 cassette enhances auto-
phosphorylation, priming the DRE for Slimb binding (Figure 6G).
DISCUSSION
The Plk4 CPB Is Two Architecturally Distinct PB
Domains
Plk4’s essential role in centriole duplication is well established,
but a fundamental understanding of its mechanism has been
lacking. Here, we have determined the structure of the Plk4
CPB and found that it is actually composed of two PB domains,
PB1-PB2. This finding recalibrates the number of PB domains in
Plk4 from one to three. Both the Plk4 PB1 and PB2 domains have
unique structural features that distinguish them from Plk1 PB1,
PB2 and Plk4 PB3.
Plk4 PB1-PB2 Has a Novel Interdomain Arrangement
and Dimerization Interface
The spatial arrangement of Plk4 PB1 and PB2 differs from the
arrangement observed in Plk1 PB1-PB2 structures. Plk4 PB1
and PB2 pack end-to-end, linked by a short, ordered threo-
nine-proline segment, flanked by hydrophobic residues that
anchor PB1 on PB2. The PBs are rotated relative to their b sheet
planes and translated, placing the 1a1 helix axis in line with the
PB2 2b2 strand. In contrast, Plk1’s tandem PBs are packed
around a pseudo 2-fold axis, forming a b sandwich. Thus, Plk4
and Plk1 each have distinct, nonhomologous arrangements of
their PB1-PB2 domains. The Plk1 PB1-PB2 structure is mono-
meric in contrast to the homodimeric Plk4 PB1-PB2 structure.
Plk4 PB1-PB2 has extensive pseudosymmetric dimerization
interfaces across PB1-PB1 and PB2-PB2. Our light scattering
data confirm a Plk4 PB1-PB2 homodimeric state, in agreement
with previous work showing that the CPB confers self-associa-
tion (Leung et al., 2002). The Plk4 PB3 structure is also homodi-
meric (Leung et al., 2002), indicating that full-length Plk4 has at
least three dimerization interfaces mediated by its three PB
domains. Overall, the three Plk4 PBs are unique among them-
selves and distinct from Plk1 PB1 and PB2 in their structure,
multidomain arrangement, and oligomeric state.
The PB1-PB2 Cassette Mediates Centriole Targeting
and Asterless Binding
Plk4 PB1-PB2 localizes robustly to centrioles in S2 cells,
whereas the individual PB1 and PB2 domains display only
weak centriole colocalization, indicating that the full PB1-PB2
cassette collectively confers strong centriole targeting. Previous
work examining Plk4’s interaction with Asl in vitro mapped the
Plk4 determinants to a segment embodying PB1 and the first
three b strands of PB2 (PB1+) (Dzhindzhev et al., 2010). In the
same study, the Plk4 PB1 region failed to bind Asl in vitro. This
maps key Plk4 Asl-binding determinants to the conserved17, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1913
Figure 6. Plk4 PB1-PB2 Promotes Centriole Amplification and Protects Full-Length Plk4 in Trans
(A) S2 cells were transiently transfected with either inducible GFP, Plk4 PB1-PB2-GFP, or nondegradable Plk4-SBM-GFP (green), induced for 3 days, fixed, and
stained for centrioles (PLP, red) and DNA (blue). Arrowheads mark centrioles. Boxed regions are magnified in the insets and highlight centriole clusters not
observed in controls.
(B) Histograms of centriole counts were measured from S2 cells transiently expressing the indicated constructs after 3 days of induction (see Figures S3 and S4).
The percentage of cells with a centriole count per cell <2, 2, and >2 is indicated. Error bars indicate standard deviation.
(C) Ectopic Plk4 PB1-PB2-GFP expression is sufficient to stabilize full-length Plk4-GFP. Immunoblots of S2 cell lysates showing that overexpression of PB1-PB2-
GFP (but not Plk4-D[PB1-PB2]-GFP or GFP) stabilizes wild-type full-length Plk4-GFP. Tubulin, loading control.
(D) PB1-PB2-GFP coimmunoprecipitates Plk4-FL-myc. Immunoblots of anti-GFP immunoprecipitates from S2 cells cotransfected with Plk4-FL-myc and PB1-
PB2-GFP or GFP (control).
(E) Anti-GFP immunoblot of Plk4-GFP constructs transiently expressed in S2 cells showing differential stability. Tubulin, loading control.
(F) Plk4-FL-GFP is expressed but rapidly degraded by Slimb-mediated ubiquitination. Cell lysates from S2 cells transfected with Plk4-FL-GFP and treated with
control or Slimb dsRNA. Tubulin, loading control.
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Structure
Structure of the Plk4 Cryptic Polo Boxinterdomain, concave junction defined by PB1 1b1 and PB2 2b1-
2b3 (Figures 4B and 4C).We found that whereas PB1+ enhances
centriole localization over PB1 alone, it is not as effective as the
full PB1-PB2 cassette. In support, we found that PB1-PB2 coim-
munoprecipitates Asl, whereas PB1+ does not. Collectively, our
work and previous work can be interpreted in light of our
PB1-PB2 structure. Whereas PB1+ contains prime Asl-binding
determinants, the remaining PB2 elements are likely required
to complete the domain fold and stabilize the determinants
that bind Asl and afford robust centriole targeting.
The PB1-PB2 Interdomain Groove and Implications
for Asterless Binding
The conserved PB1-PB2 interdomain groove contains the PB1
1b1 strand, which in Plk1 PB1 is primarily responsible for phos-
phopeptide binding. It is possible that the Plk4 PB1 1b1 strand is
used to bind Asl, but Plk1 and Plk4 target binding will have
significant differences. First, bacterially expressed Asl binds
Plk4 in vitro, indicating that the interaction, in contrast to Plk1,
is not phospho dependent. Second, Plk4 binds to a minimal,
300 residue N-terminal segment of Asl (Dzhindzhev et al.,
2010). This is in contrast to the short, phosphorylated motifs
Plk1 recognizes and suggests that Plk4 binds a domain in Asl
rather than a short motif. In support, Plk4 PB1-PB2 forms a large,
concave surface that could accommodate domain binding. This
contrasts with Plk1, where PB1 and PB2 clamp around a phos-
phopeptide target.
The PB1-PB2 Cassette Regulates Plk4 Stability
and Concomitant Centriole Number
Expression of the PB1-PB2 cassette caused interesting domi-
nant effects. First, PB1-PB2 amplified centriole levels on par
with the nondegradable Plk4-SBM construct. Second, we found
that full-length Plk4 was stabilized in trans by the PB1-PB2
construct. Plk4 downregulates its own protein level by trans-
autophosphorylating its DRE to promote Slimb binding (Holland
et al., 2010; Guderian et al., 2010). We found that the PB1-PB2
construct heterodimerizes with endogenous Plk4 and protects
it from trans-autophosphorylation. Trans-autophosphorylation
is not simply mediated by oligomerization, because a Plk4
construct lacking the PB1-PB2 cassette but retaining the PB3
homodimerization domain was itself dramatically stabilized.
This indicates that PB1-PB2 dimerization positions the kinase
domains and DREs optimally for trans-autophosphorylation in
order to restrict centriole duplication to once and only once per
cell cycle (Figure 6H).
Conclusions
Our results reveal unique structural and functional determinants
in Plk4 (Figure 6H). In contrast to Plk1-3, Plk4 is a unique polo
kinase member, containing three PBs that mediate centriole
localization as well as homodimerization. The PB1-PB2 cassette
collectively binds Asl and affords robust centriole localization,
optimally positioning the kinase domain for trans-autophosphor-(G) Plk4 lacking the PB1-PB2 cassette shows reduced autophosphorylation of
cipitates from S2 cells transfected with Plk4-FL-GFP or Plk4-D[PB1-PB2]-GFP a
(H) Model of the Plk4 homodimer. PB1 and PB2 mediate homodimerization. PB
centriole. PB1-PB2 homodimerization scaffolds Plk4 trans-autophosphorylation,
Structure 20, 1905–19ylation. Whereas PB1-PB2 affords centriole localization via Asl,
we do not rule out the possibility that PB1-PB2 interacts with
additional centriole factors. Whereas PB3 does not bind Asl
in vitro (Dzhindzhev et al., 2010), it does mediate centriole local-
ization, albeit weakly, implicating a non-Asl PB3-binding factor
at the centriole. Further structural studies are needed to illumi-
nate the Plk4/Asl interaction, understand how the PB1-PB2
cassette regulates trans-autophosphorylation, and identify addi-
tional Plk4 centriole targets.
EXPERIMENTAL PROCEDURES
Cloning and Protein Purification
D.m. Plk4 PB1-PB2 (residues 382–602) was subcloned into pET28 (Novagen),
expressed in BL21 DE3 E. coli and induced with 0.1mM IPTG for 16 hr at 20C.
Protein was purified using successive Ni2+-NTA (QIAGEN) and SP-sepharose
(GE Healthcare) chromatography. The His6 tag was proteolytically removed.
Protein was exchanged into 50 mM Tris (pH 9.5), 300 mM NaCl, 0.1% b-ME,
10% glycerol, and concentrated to 7.2 mg/ml. The SeMet-M517A mutant
was generated using standard protocols (Leahy et al., 1994).
Structure Determination and Analysis
Native Plk4 was crystallized by the hanging drop method using amother liquor
(1 ml) containing 1.2 M Li2SO4, 100mMHEPES (pH 7.5), and a drop containing
2 ml 7.2 mg/ml protein stock and 2 ml mother liquor. Native crystals were trans-
ferred to Fomblin oil (Sigma) and frozen in liquid nitrogen. SeMet-M517A
Plk4 was crystallized using a mother liquor containing 1.4 M Li2SO4,
100 mM HEPES (pH 7.5), and a drop containing 2 ml 3.2 mg/ml protein stock
and 1 ml mother liquor. Diffraction data were collected at the Advanced Photon
Source SER-CAT beamlines 22-ID and 22-BM. HKL2000 (Otwinowski and
Minor, 1997), Phenix (Adams et al., 2010), and Coot (Emsley et al., 2010)
were used to integrate and scale diffraction data, solve and refine, and build
the structure, respectively.
Centriole Localization and Count Assays
S2 cell culture was performed as described in Rogers and Rogers (2008).
Primary rabbit anti-D-PLP antibody (1:3000) and Cy3 labeled 2 antibody
(Jackson ImmunoResearch Laboratories, 1:500) were used to label centrioles
for colocalization studies. To count centriole numbers, we cotransfected S2
cells with Plk4 constructs and Nlp-EGFP (a constitutively expressed nuclear
protein) (Rogers et al., 2009), and analyzed cells with GFP-positive nuclei.
Centrioles were labeled with anti-D-PLP and a 2 antibody (conjugated with
Cy2, Rhodamine Red-X, or Cy5 [Jackson ImmunoResearch Laboratories]).
At least 200 cells were counted per construct. Statistical analyses of centriole
counts were performed using two-tailed two-sample t tests, assuming equal
variances.
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The coordinates for the Plk4 PB1-PB2 structure have been deposited in the
Protein Data Bank under accession code 4G7N.
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